Skip to main content
THC
NYSE Industrial Applications And Services

Tenet Tops Q3 Estimates and Lifts FY26 Adjusted EBITDA Outlook by $195M at the Midpoint

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$268.5
Mkt Cap
$21.619B
52W Low
$157.58
52W High
$283.05
52W Position info
70% above low
Off High info
5.1% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

THC sits 70% above its 52-week low of $157.58.

Summary

Tenet posted Q3 2026 Adjusted EBITDA of $1.355 billion, up 23.3%, and adjusted EPS of $6.64, up 79.5%, then raised FY 2026 Adjusted EBITDA guidance to $5.05-$5.20 billion and adjusted free cash flow guidance to $2.825-$3.125 billion.


Key Events · Earnings and Guidance · THC

  • Q3 Adjusted EBITDA Jumps 23.3%

    Adjusted EBITDA reached $1.355 billion versus $1.099 billion a year ago, a 24.1% margin, on net operating revenues of $5.631 billion (up 6.5%).

  • Adjusted EPS Up 79.5%

    Adjusted diluted EPS rose to $6.64 from $3.70, while GAAP diluted EPS was $12.41, including $646 million of contract termination revenue.

  • FY26 EBITDA Outlook Raised $195M

    Full-year Adjusted EBITDA guidance now sits at $5.05-$5.20 billion, a $195 million increase at the midpoint, alongside revenue of $22.05-$22.45 billion.

  • Free Cash Flow Outlook Lifted $100M

    Adjusted free cash flow guidance rose to $2.825-$3.125 billion; year-to-date adjusted free cash flow was $2.524 billion versus $2.247 billion.


Analysis · THC · Industrial Applications And Services

The headline beat is real but partly optical: Adjusted EBITDA climbed 23.3% to $1.355 billion and adjusted diluted EPS jumped 79.5% to $6.64, yet roughly $147 million of the quarterly EBITDA gain came from the accelerated Conifer/CommonSpirit revenue-cycle transition, a timing benefit management says does not change full-year expectations. Strip that out and the underlying beat is smaller than it looks. Still, guidance moved higher: full-year Adjusted EBITDA is now $5.05-$5.20 billion, a $195 million increase at the midpoint, and the adjusted free cash flow range was lifted to $2.825-$3.125 billion. Net leverage of 2.11x, down from 2.33x, reinforces the picture of a business generating cash faster than planned.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, THC was trading at $268.50 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $21.6B. The 52-week trading range was $157.58 to $283.05. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

THC - Latest Insights

THC
Oct 29, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $270.57
Real-time Price: $286.03 info
Change: +$15.46 (+6%) info
Market Cap: $22.765B info
THC
Oct 29, 2026, 1:27 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $263.65
Real-time Price: $286.03 info
Change: +$22.38 (+8%) info
Market Cap: $22.765B info
THC
Oct 29, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $268.50
Real-time Price: $286.03 info
Change: +$17.53 (+7%) info
Market Cap: $22.765B info
THC
Sep 08, 2026, 5:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $259.06
Real-time Price: $286.03 info
Change: +$26.97 (+10%) info
Market Cap: $22.765B info
THC
Sep 08, 2026, 5:00 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $259.06
Real-time Price: $286.03 info
Change: +$26.97 (+10%) info
Market Cap: $22.765B info